Circulating Levels of Soluble Angiogenic Factors in Multiple Myeloma: Correlation with Parameters of Disease Activity and Prognosis

ISSN: 2211-5536 (Online)
ISSN: 2211-5528 (Print)

Volume 4, 2 Issues, 2015

Download PDF Flyer

Current Angiogenesis

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Guo-Chang Fan
Dept. of Pharmacology and Cell Biophysics
University of Cincinnati College of Medicine

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Circulating Levels of Soluble Angiogenic Factors in Multiple Myeloma: Correlation with Parameters of Disease Activity and Prognosis

Current Angiogenesis, 2(2): 76-95.

Author(s): Michael G. Alexandrakis and George Tsirakis.

Affiliation: Hematology Dept., University Hospital of Heraklion, Voutes, Heraklion, Crete, Greece, Zip code: 71110, P.O. Box1352.


The progression of multiple myeloma depends on bone marrow microenvironment that can offer favorable conditions for its growth. Among the most important features of the disease is the alteration of bone marrow microenvironment, including dysregulation of various molecules with consequent increased angiogenic potential, extended bone disease, resistance to any likely therapy and furthermore direct growth of myeloma clone. Angiogenesis, as can be estimated by immunohistochemical staining of blood vessels, i.e. microvascular density, is a hallmark in the progress of many malignancies, including multiple myeloma. Many pro-angiogenic molecules participate in the process, being aberrantly or over-expressed by myeloma and other cells of bone marrow. Those molecules, possessing multiple properties, may circulate in peripheral blood and therefore could be measured. Here we present an overview of the most important molecules that participate, directly and indirectly, in the angiogenic process of multiple myeloma and try to evaluate their role, as factors of disease activity and moreover of prognosis. Furthermore, many of circulating angiogenic molecules have been constituted possible targets for therapeutic interventions. All this provided information contributes to a better comprehension of the complex pathophysiology of multiple myeloma.


Angiogenesis, bone marrow, chemokines, cytokines, microvascular density, multiple myeloma, prognosis.

Download Free Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 2
Issue Number: 2
First Page: 76
Last Page: 95
Page Count: 20
DOI: 10.2174/22115528113026660012
Global Biotechnology Congress 2016Drug Discovery and Therapy World Congress 2016

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science